Secondary |
Product Used For Unknown Indication |
26.2% |
Drug Use For Unknown Indication |
13.9% |
Acute Lymphocytic Leukaemia |
6.5% |
Pain |
5.9% |
Bipolar Disorder |
5.6% |
Rheumatoid Arthritis |
5.6% |
Nasopharyngitis |
4.9% |
Pyoderma Gangrenosum |
3.7% |
Asthma |
3.1% |
Crohn's Disease |
3.1% |
Peritoneal Dialysis |
2.8% |
Gastrooesophageal Reflux Disease |
2.5% |
Hepatitis C |
2.5% |
Bronchitis |
2.2% |
Infection |
2.2% |
Pneumonia |
2.2% |
Antibiotic Therapy |
1.9% |
Breast Cancer |
1.9% |
Pyrexia |
1.9% |
Skin Infection |
1.9% |
|
Vomiting |
11.1% |
Weight Decreased |
11.1% |
Pneumonia |
9.5% |
Rash |
9.5% |
Drug Interaction |
4.8% |
Pyrexia |
4.8% |
Sinusitis |
4.8% |
Stomach Discomfort |
4.8% |
Suicide Attempt |
4.8% |
Adverse Drug Reaction |
3.2% |
Clostridial Infection |
3.2% |
Crohn's Disease |
3.2% |
Death |
3.2% |
Diarrhoea |
3.2% |
Dysphagia |
3.2% |
Fatigue |
3.2% |
Hepatotoxicity |
3.2% |
Hypoacusis |
3.2% |
Laryngitis |
3.2% |
Local Swelling |
3.2% |
|
Concomitant |
Product Used For Unknown Indication |
26.7% |
Drug Use For Unknown Indication |
8.5% |
Prophylaxis |
8.4% |
Maintenance Of Anaesthesia |
6.2% |
Multiple Myeloma |
5.6% |
Crohn's Disease |
4.9% |
Asthma |
3.8% |
Rheumatoid Arthritis |
3.6% |
Arrhythmia |
3.1% |
Induction Of Anaesthesia |
3.1% |
Laryngospasm |
3.1% |
Burkitt's Lymphoma |
2.9% |
Depression |
2.7% |
Inflammatory Bowel Disease |
2.7% |
Bronchitis |
2.6% |
Hypertension |
2.5% |
B Precursor Type Acute Leukaemia |
2.5% |
Pain |
2.5% |
Acne |
2.4% |
Chronic Obstructive Pulmonary Disease |
2.3% |
|
Vomiting |
10.9% |
Unwanted Awareness During Anaesthesia |
9.1% |
Neuropathy Peripheral |
7.3% |
Visual Disturbance |
6.1% |
Drug Ineffective |
5.8% |
Pyrexia |
5.8% |
Rash |
5.8% |
Urinary Tract Infection |
5.2% |
Weight Decreased |
5.2% |
Wheezing |
4.9% |
Crohn's Disease |
4.6% |
Hypoxia |
4.3% |
White Blood Cell Count Decreased |
4.0% |
Pneumonia |
3.6% |
Stomatitis |
3.6% |
Nausea |
3.0% |
Product Quality Issue |
3.0% |
Tremor |
3.0% |
Colitis Ulcerative |
2.4% |
Malaise |
2.4% |
|
Interacting |
Drug Use For Unknown Indication |
40.0% |
Ear Infection |
13.3% |
Bronchitis Chronic |
6.7% |
Chronic Obstructive Pulmonary Disease |
6.7% |
Convulsion Prophylaxis |
6.7% |
Gastrooesophageal Reflux Disease |
6.7% |
Hypothyroidism |
6.7% |
Oesophageal Disorder |
6.7% |
Tooth Infection |
6.7% |
|
Drug Interaction |
20.0% |
Headache |
20.0% |
Off Label Use |
20.0% |
Renal Failure Acute |
20.0% |
Vision Blurred |
20.0% |
|